Chang David J. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Chang David J. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $20K.
Profile
David J. Chang is listed as Chief Medical Officer of Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on engineered T cell therapies (CAART cells) for B cell-mediated autoimmune diseases, according to SEC filings dated 2026-01-21. The filing indicates no purchases or sales of Cabaletta Bio securities by him in that period.
Role
Insider
Notability
45/100
Board memberships
Cabaletta Bio, Inc.
Awards & honors
Chief Medical Officer at Cabaletta Bio, Inc.
Affiliated with Cabaletta Bio's CAART cell therapy program leadership
David J. Chang is listed as Chief Medical Officer of Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on engineered T cell therapies (CAART cells) for B cell-mediated autoimmune diseases, according to SEC filings dated 2026-01-21. The filing indicates no purchases or sales of Cabaletta Bio securities by him in that period.…
Has Chang David J. been buying or selling stock?
Recorded transactions: 1 open-market purchases ($20K) and 0 open-market sales () across all tracked filings.
Where can I see all of Chang David J.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
